NON-ST-SEGMENT-ELEVATION ACUTE CORONARY SYNDROME: PREVENTION DRUG THERAPY

Abstract

Nowadays, cardiovascular diseases (CVDs) that comprise a major portion of chronic non-communicable diseases are the leading cause of disease burdent and death in developed countries. The term acute coronary syndrome (ACS) covers any group of clinical symptoms consistent with acute myocardial ischemia. The classification of the ACS is based primarily on electrocardiogram (ECG) data. Depending on the ECG changes, the ACS is divided into patients with ST elevation (STE-ACS) versus patients with non-STelevation (NSTE-ACS). NSTE-ACS is increasingly the cause of hospitalization. There are conflicting views in the literature on the therapeutic strategies applied to different types of ACS. The strategies applied in the ACS need to take into account the patient‘s objective condition and accompanying illnesses to reduce shortand long-term mortality. Patients with NSTE-ACS are a non-homogeneous group against the risk of adverse cardiovascular events (MACE). The choice of a medical strategy for patients with NSTE-ACS is based on an individual case-by-case assessment. Cardioprotection is an integral part of the prevention of cardiovascular disease. The main purpose of prophylactic drug therapy in patients with cardiovascular diseases is to maximize the reduction of long-term risk for MACE and cerebrovascular disease; reducing recurrences and complications, requiring control of all identified risk factors. The purpose of this study is to review the literature on NSTE-ACS strategies in patients with a different risk profile and age; to determine which prophylactic drug therapy, tailored to the patient‘s objective condition and accompanying conditions, is assigned to patients with non-ST-elevation (NSTE-ACS) in order to prevent recurrences and complications.

Authors and Affiliations

Valentin Balabanski, Iliana Yaneva

Keywords

Related Articles

THE MALMQUIST PRODUCTIVITY INDEX – METHODOLOGY AND PRACTICAL APPLICATION IN HEALTHCARE

The present article deals with the themes of efficiency and productivity in healthcare. One of the most widely used productivity indices, the Malmquist productivity index, is presented. We also comment on the methodolog...

MYCOTOXICS AS HEALTH HAZARDS IN WORK ENVIRONMENT

Contrary to fungi, exposure to mycotoxins is not usually identified as a risk factor present in occupational settings. This is probably due to the inexistence of limits regarding concentration of airborne mycotoxins, and...

HEALTH IMPACT ASSESSMENT OF MUNICIPAL POLICIES AS AN INSTRUMENT FOR IMPROVING PUBLIC HEALTH

Reason There is plenty of scientific evidence about policies beyond healthcare sector such as economics, ecology, education, culture and living conditions, which have impact on health. Health impact assessment (HIA) on t...

EFFECTS OF INVISIBLE DISABILITIES ON LAWYERS WORK

The paper is aimed to draw professionals’ and public attention to the difficulties facing lawyers with the so called non-visible disabilities (NVD) as a way to tackle them successful. Contemporary disability terms are de...

OCCUPATIONAL BLOOD EXPOSURES IN HEALTHCARE WORKERS IN THE HOSPITAL SETTING

Introduction: Health workers are a group at risk for injuries with a contaminated sharp objects. Purpose: Assessment of occupational exposure to blood and biological materials in hospital healthcare workers. Methods: In...

Download PDF file
  • EP ID EP471010
  • DOI -
  • Views 41
  • Downloads 0

How To Cite

Valentin Balabanski, Iliana Yaneva (2018). NON-ST-SEGMENT-ELEVATION ACUTE CORONARY SYNDROME: PREVENTION DRUG THERAPY. Българско списание за обществено здраве (Bulgarian Journal of Public Health), 0(1), 67-77. https://europub.co.uk/articles/-A-471010